HEADER HYDROLASE 30-AUG-12 4GVF TITLE CRYSTAL STRUCTURE OF SALMONELLA TYPHIMURIUM FAMILY 3 GLYCOSIDE TITLE 2 HYDROLASE (NAGZ) BOUND TO GLCNAC COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-HEXOSAMINIDASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: BETA-N-ACETYLHEXOSAMINIDASE, N-ACETYL-BETA-GLUCOSAMINIDASE; COMPND 5 EC: 3.2.1.52; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR SOURCE 3 TYPHIMURIUM; SOURCE 4 ORGANISM_TAXID: 99287; SOURCE 5 STRAIN: LT2 / SGSC1412 / ATCC 700720; SOURCE 6 GENE: NAGZ, STM1209; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TIM-BARREL, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR J.P.BACIK,B.L.MARK REVDAT 4 28-FEB-24 4GVF 1 HETSYN REVDAT 3 29-JUL-20 4GVF 1 COMPND REMARK SEQADV HETNAM REVDAT 3 2 1 SITE ATOM REVDAT 2 16-JAN-13 4GVF 1 HETATM REMARK REVDAT 1 19-DEC-12 4GVF 0 JRNL AUTH J.P.BACIK,G.E.WHITWORTH,K.A.STUBBS,D.J.VOCADLO,B.L.MARK JRNL TITL ACTIVE SITE PLASTICITY WITHIN THE GLYCOSIDE HYDROLASE NAGZ JRNL TITL 2 UNDERLIES A DYNAMIC MECHANISM OF SUBSTRATE DISTORTION. JRNL REF CHEM.BIOL. V. 19 1471 2012 JRNL REFN ISSN 1074-5521 JRNL PMID 23177201 JRNL DOI 10.1016/J.CHEMBIOL.2012.09.016 REMARK 2 REMARK 2 RESOLUTION. 1.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.6.4_486) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.89 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.9 REMARK 3 NUMBER OF REFLECTIONS : 128758 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.168 REMARK 3 R VALUE (WORKING SET) : 0.167 REMARK 3 FREE R VALUE : 0.190 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.020 REMARK 3 FREE R VALUE TEST SET COUNT : 3884 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.9228 - 2.9083 1.00 13089 402 0.1596 0.1809 REMARK 3 2 2.9083 - 2.3084 1.00 12921 399 0.1687 0.2014 REMARK 3 3 2.3084 - 2.0166 1.00 12868 394 0.1614 0.1746 REMARK 3 4 2.0166 - 1.8322 0.99 12761 391 0.1653 0.1818 REMARK 3 5 1.8322 - 1.7009 0.99 12718 396 0.1606 0.1951 REMARK 3 6 1.7009 - 1.6006 0.98 12648 400 0.1593 0.1775 REMARK 3 7 1.6006 - 1.5204 0.98 12549 392 0.1602 0.1976 REMARK 3 8 1.5204 - 1.4542 0.96 12372 384 0.1761 0.1903 REMARK 3 9 1.4542 - 1.3983 0.94 12103 383 0.1974 0.2295 REMARK 3 10 1.3983 - 1.3500 0.85 10845 343 0.2181 0.2217 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.00 REMARK 3 SHRINKAGE RADIUS : 0.72 REMARK 3 K_SOL : 0.35 REMARK 3 B_SOL : 43.63 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.160 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 17.880 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 9.14 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.79790 REMARK 3 B22 (A**2) : 4.79130 REMARK 3 B33 (A**2) : -1.99350 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.01080 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 5366 REMARK 3 ANGLE : 1.066 7279 REMARK 3 CHIRALITY : 0.067 794 REMARK 3 PLANARITY : 0.005 965 REMARK 3 DIHEDRAL : 16.555 2043 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4GVF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-SEP-12. REMARK 100 THE DEPOSITION ID IS D_1000074681. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-MAR-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CLSI REMARK 200 BEAMLINE : 08ID-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-300 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 131665 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.350 REMARK 200 RESOLUTION RANGE LOW (A) : 48.890 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : 0.07000 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.35 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.7 REMARK 200 DATA REDUNDANCY IN SHELL : 2.80 REMARK 200 R MERGE FOR SHELL (I) : 0.23400 REMARK 200 R SYM FOR SHELL (I) : 0.29000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.05 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.99 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M MES, 25% PEG 1000, PH 6.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 296K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.11650 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 341 REMARK 465 GLY A 342 REMARK 465 SER A 343 REMARK 465 HIS A 344 REMARK 465 HIS A 345 REMARK 465 HIS A 346 REMARK 465 HIS A 347 REMARK 465 HIS A 348 REMARK 465 HIS A 349 REMARK 465 ALA B 173 REMARK 465 ASP B 174 REMARK 465 SER B 175 REMARK 465 HIS B 176 REMARK 465 LYS B 177 REMARK 465 MET B 252 REMARK 465 GLU B 253 REMARK 465 GLY B 254 REMARK 465 ALA B 255 REMARK 465 ALA B 256 REMARK 465 ILE B 257 REMARK 465 MET B 258 REMARK 465 GLY B 259 REMARK 465 GLY B 342 REMARK 465 SER B 343 REMARK 465 HIS B 344 REMARK 465 HIS B 345 REMARK 465 HIS B 346 REMARK 465 HIS B 347 REMARK 465 HIS B 348 REMARK 465 HIS B 349 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 34 CZ NH1 NH2 REMARK 470 ASP A 174 CG OD1 OD2 REMARK 470 LYS A 177 CG CD CE NZ REMARK 470 ARG A 217 CG CD NE CZ NH1 NH2 REMARK 470 ILE A 257 CG1 CG2 CD1 REMARK 470 LYS A 283 CG CD CE NZ REMARK 470 LYS A 296 CG CD CE NZ REMARK 470 LYS A 306 CE NZ REMARK 470 GLU A 332 CG CD OE1 OE2 REMARK 470 GLU B 178 CG CD OE1 OE2 REMARK 470 ARG B 217 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 306 CE NZ REMARK 470 GLN B 329 CG CD OE1 NE2 REMARK 470 ARG B 333 CG CD NE CZ NH1 NH2 REMARK 470 HIS B 341 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 37 -50.86 -123.19 REMARK 500 ARG A 72 -70.74 -107.65 REMARK 500 ARG A 72 -74.08 -105.09 REMARK 500 ILE A 130 -67.28 -108.39 REMARK 500 LYS A 192 -78.84 -96.02 REMARK 500 ASN A 281 87.41 -159.15 REMARK 500 SER A 308 35.78 -154.91 REMARK 500 HIS B 37 -50.72 -124.42 REMARK 500 ARG B 72 -70.68 -108.81 REMARK 500 ILE B 130 -66.90 -104.57 REMARK 500 LYS B 192 -79.74 -95.51 REMARK 500 ASN B 281 86.45 -163.46 REMARK 500 SER B 308 30.50 -152.00 REMARK 500 REMARK 500 REMARK: NULL DBREF 4GVF A 1 341 UNP Q8ZQ06 NAGZ_SALTY 1 341 DBREF 4GVF B 1 341 UNP Q8ZQ06 NAGZ_SALTY 1 341 SEQADV 4GVF GLY A 342 UNP Q8ZQ06 EXPRESSION TAG SEQADV 4GVF SER A 343 UNP Q8ZQ06 EXPRESSION TAG SEQADV 4GVF HIS A 344 UNP Q8ZQ06 EXPRESSION TAG SEQADV 4GVF HIS A 345 UNP Q8ZQ06 EXPRESSION TAG SEQADV 4GVF HIS A 346 UNP Q8ZQ06 EXPRESSION TAG SEQADV 4GVF HIS A 347 UNP Q8ZQ06 EXPRESSION TAG SEQADV 4GVF HIS A 348 UNP Q8ZQ06 EXPRESSION TAG SEQADV 4GVF HIS A 349 UNP Q8ZQ06 EXPRESSION TAG SEQADV 4GVF GLY B 342 UNP Q8ZQ06 EXPRESSION TAG SEQADV 4GVF SER B 343 UNP Q8ZQ06 EXPRESSION TAG SEQADV 4GVF HIS B 344 UNP Q8ZQ06 EXPRESSION TAG SEQADV 4GVF HIS B 345 UNP Q8ZQ06 EXPRESSION TAG SEQADV 4GVF HIS B 346 UNP Q8ZQ06 EXPRESSION TAG SEQADV 4GVF HIS B 347 UNP Q8ZQ06 EXPRESSION TAG SEQADV 4GVF HIS B 348 UNP Q8ZQ06 EXPRESSION TAG SEQADV 4GVF HIS B 349 UNP Q8ZQ06 EXPRESSION TAG SEQRES 1 A 349 MET GLY PRO VAL MET LEU ASN VAL GLU GLY CYS GLU LEU SEQRES 2 A 349 ASP ALA GLU GLU ARG GLU ILE LEU ALA HIS PRO LEU VAL SEQRES 3 A 349 GLY GLY LEU ILE LEU PHE THR ARG ASN TYR HIS ASP PRO SEQRES 4 A 349 GLU GLN LEU ARG GLU LEU VAL ARG GLN ILE ARG ALA ALA SEQRES 5 A 349 SER ARG ASN HIS LEU VAL VAL ALA VAL ASP GLN GLU GLY SEQRES 6 A 349 GLY ARG VAL GLN ARG PHE ARG GLU GLY PHE THR ARG LEU SEQRES 7 A 349 PRO ALA ALA GLN SER PHE PHE ALA LEU HIS GLY LEU GLU SEQRES 8 A 349 GLU GLY GLY ARG LEU ALA GLN GLU ALA GLY TRP LEU MET SEQRES 9 A 349 ALA SER GLU MET ILE ALA MET ASP ILE ASP ILE SER PHE SEQRES 10 A 349 ALA PRO VAL LEU ASP VAL GLY HIS ILE SER ALA ALA ILE SEQRES 11 A 349 GLY GLU ARG SER TYR HIS ALA ASP PRO ALA LYS ALA LEU SEQRES 12 A 349 ALA MET ALA THR ARG PHE ILE ASP GLY MET HIS ASP ALA SEQRES 13 A 349 GLY MET LYS THR THR GLY LYS HIS PHE PRO GLY HIS GLY SEQRES 14 A 349 ALA VAL THR ALA ASP SER HIS LYS GLU THR PRO CYS ASP SEQRES 15 A 349 PRO ARG PRO GLU THR ASP ILE ARG GLY LYS ASP MET SER SEQRES 16 A 349 VAL PHE ARG THR LEU ILE SER GLU ASN LYS LEU ASP ALA SEQRES 17 A 349 ILE MET PRO ALA HIS VAL ILE TYR ARG ALA ILE ASP PRO SEQRES 18 A 349 ARG PRO ALA SER GLY SER PRO TYR TRP LEU LYS THR VAL SEQRES 19 A 349 LEU ARG GLN GLU LEU GLY PHE ASP GLY VAL ILE PHE SER SEQRES 20 A 349 ASP ASP LEU SER MET GLU GLY ALA ALA ILE MET GLY SER SEQRES 21 A 349 TYR ALA GLU ARG ALA GLN ALA SER LEU ASP ALA GLY CYS SEQRES 22 A 349 ASP MET ILE LEU VAL CYS ASN ASN ARG LYS GLY ALA VAL SEQRES 23 A 349 SER VAL LEU ASP ASN LEU SER PRO ILE LYS ALA GLU ARG SEQRES 24 A 349 VAL THR ARG LEU TYR HIS LYS GLY SER PHE SER ARG ARG SEQRES 25 A 349 GLU LEU MET ASP SER ALA ARG TRP LYS THR ALA SER ALA SEQRES 26 A 349 GLN LEU ASN GLN LEU HIS GLU ARG TRP GLN GLU GLU LYS SEQRES 27 A 349 ALA GLY HIS GLY SER HIS HIS HIS HIS HIS HIS SEQRES 1 B 349 MET GLY PRO VAL MET LEU ASN VAL GLU GLY CYS GLU LEU SEQRES 2 B 349 ASP ALA GLU GLU ARG GLU ILE LEU ALA HIS PRO LEU VAL SEQRES 3 B 349 GLY GLY LEU ILE LEU PHE THR ARG ASN TYR HIS ASP PRO SEQRES 4 B 349 GLU GLN LEU ARG GLU LEU VAL ARG GLN ILE ARG ALA ALA SEQRES 5 B 349 SER ARG ASN HIS LEU VAL VAL ALA VAL ASP GLN GLU GLY SEQRES 6 B 349 GLY ARG VAL GLN ARG PHE ARG GLU GLY PHE THR ARG LEU SEQRES 7 B 349 PRO ALA ALA GLN SER PHE PHE ALA LEU HIS GLY LEU GLU SEQRES 8 B 349 GLU GLY GLY ARG LEU ALA GLN GLU ALA GLY TRP LEU MET SEQRES 9 B 349 ALA SER GLU MET ILE ALA MET ASP ILE ASP ILE SER PHE SEQRES 10 B 349 ALA PRO VAL LEU ASP VAL GLY HIS ILE SER ALA ALA ILE SEQRES 11 B 349 GLY GLU ARG SER TYR HIS ALA ASP PRO ALA LYS ALA LEU SEQRES 12 B 349 ALA MET ALA THR ARG PHE ILE ASP GLY MET HIS ASP ALA SEQRES 13 B 349 GLY MET LYS THR THR GLY LYS HIS PHE PRO GLY HIS GLY SEQRES 14 B 349 ALA VAL THR ALA ASP SER HIS LYS GLU THR PRO CYS ASP SEQRES 15 B 349 PRO ARG PRO GLU THR ASP ILE ARG GLY LYS ASP MET SER SEQRES 16 B 349 VAL PHE ARG THR LEU ILE SER GLU ASN LYS LEU ASP ALA SEQRES 17 B 349 ILE MET PRO ALA HIS VAL ILE TYR ARG ALA ILE ASP PRO SEQRES 18 B 349 ARG PRO ALA SER GLY SER PRO TYR TRP LEU LYS THR VAL SEQRES 19 B 349 LEU ARG GLN GLU LEU GLY PHE ASP GLY VAL ILE PHE SER SEQRES 20 B 349 ASP ASP LEU SER MET GLU GLY ALA ALA ILE MET GLY SER SEQRES 21 B 349 TYR ALA GLU ARG ALA GLN ALA SER LEU ASP ALA GLY CYS SEQRES 22 B 349 ASP MET ILE LEU VAL CYS ASN ASN ARG LYS GLY ALA VAL SEQRES 23 B 349 SER VAL LEU ASP ASN LEU SER PRO ILE LYS ALA GLU ARG SEQRES 24 B 349 VAL THR ARG LEU TYR HIS LYS GLY SER PHE SER ARG ARG SEQRES 25 B 349 GLU LEU MET ASP SER ALA ARG TRP LYS THR ALA SER ALA SEQRES 26 B 349 GLN LEU ASN GLN LEU HIS GLU ARG TRP GLN GLU GLU LYS SEQRES 27 B 349 ALA GLY HIS GLY SER HIS HIS HIS HIS HIS HIS HET NDG A 401 15 HET NAG A 402 15 HET NDG B 401 15 HET MES B 403 12 HET NAG B 402 15 HETNAM NDG 2-ACETAMIDO-2-DEOXY-ALPHA-D-GLUCOPYRANOSE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID HETSYN NDG N-ACETYL-ALPHA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY- HETSYN 2 NDG ALPHA-D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2- HETSYN 3 NDG ACETAMIDO-2-DEOXY-GLUCOSE; 2-(ACETYLAMINO)-2-DEOXY-A- HETSYN 4 NDG D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 NDG 2(C8 H15 N O6) FORMUL 4 NAG 2(C8 H15 N O6) FORMUL 6 MES C6 H13 N O4 S FORMUL 8 HOH *988(H2 O) HELIX 1 1 ASP A 14 ALA A 22 1 9 HELIX 2 2 PHE A 32 TYR A 36 5 5 HELIX 3 3 ASP A 38 SER A 53 1 16 HELIX 4 4 GLN A 82 ALA A 110 1 29 HELIX 5 5 ILE A 130 SER A 134 5 5 HELIX 6 6 ASP A 138 GLY A 157 1 20 HELIX 7 7 PRO A 185 LYS A 192 1 8 HELIX 8 8 LYS A 192 GLU A 203 1 12 HELIX 9 9 PRO A 223 GLY A 226 5 4 HELIX 10 10 SER A 227 LYS A 232 1 6 HELIX 11 11 SER A 251 GLU A 253 5 3 HELIX 12 12 ALA A 255 GLY A 259 5 5 HELIX 13 13 SER A 260 GLY A 272 1 13 HELIX 14 14 ASN A 281 LEU A 292 1 12 HELIX 15 15 ALA A 297 TYR A 304 5 8 HELIX 16 16 SER A 310 SER A 317 1 8 HELIX 17 17 SER A 317 GLY A 340 1 24 HELIX 18 18 ASP B 14 ALA B 22 1 9 HELIX 19 19 PHE B 32 TYR B 36 5 5 HELIX 20 20 ASP B 38 SER B 53 1 16 HELIX 21 21 GLN B 82 ALA B 110 1 29 HELIX 22 22 ILE B 130 SER B 134 5 5 HELIX 23 23 ASP B 138 GLY B 157 1 20 HELIX 24 24 PRO B 185 LYS B 192 1 8 HELIX 25 25 LYS B 192 GLU B 203 1 12 HELIX 26 26 PRO B 223 GLY B 226 5 4 HELIX 27 27 SER B 227 LYS B 232 1 6 HELIX 28 28 TYR B 261 GLY B 272 1 12 HELIX 29 29 ASN B 281 LEU B 292 1 12 HELIX 30 30 ALA B 297 TYR B 304 5 8 HELIX 31 31 SER B 310 SER B 317 1 8 HELIX 32 32 SER B 317 GLY B 340 1 24 SHEET 1 A 8 ILE A 115 SER A 116 0 SHEET 2 A 8 VAL A 58 VAL A 61 1 N VAL A 59 O ILE A 115 SHEET 3 A 8 VAL A 26 LEU A 31 1 N LEU A 29 O ALA A 60 SHEET 4 A 8 VAL A 4 LEU A 6 1 N VAL A 4 O GLY A 27 SHEET 5 A 8 MET A 275 VAL A 278 1 O ILE A 276 N MET A 5 SHEET 6 A 8 VAL A 244 ASP A 249 1 N SER A 247 O MET A 275 SHEET 7 A 8 ALA A 208 PRO A 211 1 N ILE A 209 O VAL A 244 SHEET 8 A 8 THR A 161 PHE A 165 1 N GLY A 162 O MET A 210 SHEET 1 B 2 GLN A 63 GLY A 65 0 SHEET 2 B 2 VAL A 68 GLN A 69 -1 O VAL A 68 N GLY A 65 SHEET 1 C 8 ILE B 115 SER B 116 0 SHEET 2 C 8 VAL B 58 VAL B 61 1 N VAL B 59 O ILE B 115 SHEET 3 C 8 VAL B 26 LEU B 31 1 N LEU B 29 O ALA B 60 SHEET 4 C 8 VAL B 4 LEU B 6 1 N VAL B 4 O GLY B 27 SHEET 5 C 8 MET B 275 VAL B 278 1 O ILE B 276 N MET B 5 SHEET 6 C 8 VAL B 244 ASP B 249 1 O ILE B 245 N MET B 275 SHEET 7 C 8 ALA B 208 PRO B 211 1 N ILE B 209 O VAL B 244 SHEET 8 C 8 THR B 161 PHE B 165 1 N GLY B 162 O MET B 210 SHEET 1 D 2 GLN B 63 GLY B 65 0 SHEET 2 D 2 VAL B 68 GLN B 69 -1 O VAL B 68 N GLY B 65 CISPEP 1 ALA A 118 PRO A 119 0 8.08 CISPEP 2 LYS A 163 HIS A 164 0 2.60 CISPEP 3 PHE A 165 PRO A 166 0 3.10 CISPEP 4 ALA B 118 PRO B 119 0 8.08 CISPEP 5 LYS B 163 HIS B 164 0 4.49 CISPEP 6 PHE B 165 PRO B 166 0 3.53 CRYST1 49.544 66.233 94.968 90.00 99.32 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020184 0.000000 0.003313 0.00000 SCALE2 0.000000 0.015098 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010671 0.00000